Roth Capital Downgrades IGI Laboratories (IG) to Neutral
Tweet
Share
E-mailGet Alerts IG Hot Sheet
Price: $20.02 --0%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 36
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 36
Join SI Premium – FREE
Roth Capital downgraded IGI Laboratories (NYSE: IG) from Buy to Neutral with a price target of $10.00 (from $11.00).
For an analyst ratings summary and ratings history on IGI Laboratories click here. For more ratings news on IGI Laboratories click here.
Shares of IGI Laboratories closed at $9.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ionis Pharmaceuticals (IONS) PT Lowered to $70 at JPMorgan Amid Negative Sentiment
- Hugel (145020:KS) PT Lowered to KRW320,000 at Citi
- Kymera Therapeutics (KYMR) PT Raised to $152 at Stifel on Ph2b BROADEN2 Data
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
